Loading clinical trials...

Thyme Honey for Management of Oral Lichen Planus | Clinical Trials | Clareo Health

ENROLLING_BY_INVITATIONPHASE1/PHASE2

Thyme Honey for Management of Oral Lichen Planus

Thyme Honey for Management of Oral Lichen Planus: A Non- Inferiority Controlled Randomized Clinical Trial

NCT06810752•British University In Egypt

Summary

the study aimed to assess the effect of topical application of thyme honey in comparison to 0.1% triamcinolone acetonide oral paste on the relief of pain and clinical improvement in patients with OLP

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients free from any visible oral lesions other than OLP.
•Patients who agreed to take supplied medications.
•Patients who agreed for the biopsy (when required).

Exclusion Criteria

•Treatment with any systemic treatment such as systemic steroids, other immunosuppressive drugs or non-steroidal anti-inflammatory drugs at least eight weeks.
•Treatment with any oral topical medications for at least four weeks prior to the study.
•Pregnant and lactating women.
•In addition, no consideration was given to patients with a history of hypersensitivity to honey.

Locations (1)

The British university in Egypt

Cairo, Egypt

Key Dates

Start Date

October 12, 2024

Primary Completion Date

February 1, 2025

Completion Date

March 1, 2025

Last Updated

February 6, 2025

Enrollment

ESTIMATED participants

Conditions

Oral Lichen Planus

Interventions

thyme honey

DIETARY_SUPPLEMENT

Triamcinolone Acetonide

DRUG

Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus

NCT07131813

Oral Lichen Planus

View study

RECRUITING

SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography

NCT06321003

Oral Squamous Cell CarcinomaOral Potentially Malignant Disorder+10 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 6, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Thyme Honey for Management of Oral Lichen Planus

Inclusion Criteria

Exclusion Criteria

Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen Planus

SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography

Dual-light Antibacterial Photodynamic Therapy as an Adjunctive Treatment to Corticosteroid Treatment in OLP

Evaluation of Artificial Intelligence in Diagnosis and Risk Assessment of Oral Potentially Malignant Disorders

Relationship Between Oral Lichen Planus and Autoimmune Thyroid Diseases

Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-control Study.